Meet Merck’s Dealmaker: A Conversation With Roger Pomerantz

Merck’s new head of worldwide licensing and knowledge management Roger Pomerantz, MD, talks with IN VIVO about Merck’s business development strategy, whether biotech passion can exist on a Big Pharma scale, and the art of the deal.

On December 1, 2011, Merck & Co. Inc. introduced Roger Pomerantz, MD, as its new SVP and head, worldwide licensing and knowledge management.

Pomerantz replaces David Nicholson, PhD, the Organon and then Schering-Plough executive who had led business development at Merck since late...

More from Business Strategy

More from In Vivo